LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Chemotherapy drugs may have different effects in patients with
different degrees of kidney function.
PURPOSE: Phase I trial to study the effectiveness of LY231514 in treating patients who have
locally advanced or metastatic solid tumors and varying degrees of kidney function.
Phase:
Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborators:
Lily Research Laboratories National Cancer Institute (NCI)